FIELD: chemistry.
SUBSTANCE: use of disodium salt of 4,4'-di(sulphophenyl) sulphone as a hypolipidemic and an antiatherosclerotic agent during treatment of dislipoproteinemia of atherogenic nature and atherosclerosis of various localisation is proposed. The proposed preparation reduces level of cholesterol and triglycerides in blood plasma (hypolipidemic action), reduces cholesterol content in the aorta and degree of its atherosclerotic damage (antiatherosclerotic action).
EFFECT: preparation exhibits low toxicity and efficiency during oral administration.
5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENT | 2007 |
|
RU2372923C2 |
| AGENT POSSESSING HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTIVITY | 2015 |
|
RU2598347C1 |
| HYPOLIPIDEMIC AGENT | 2008 |
|
RU2392933C2 |
| AGENT WITH HYPOLIPIDEMIC ACTIVITY | 2004 |
|
RU2268714C1 |
| PHARMACEUTICAL COMPOSITION POSSESSING HEPATOPROTECTING, HYPOLIPIDEMIC, IMMUNOSTIMULATING AND NORMALISING KIDNEY FUNCTION ACTION, AND METHOD OF ITS OBTAINING | 2011 |
|
RU2483712C2 |
| METHOD FOR DIAGNOSING LIPIDEMIA | 2019 |
|
RU2694531C1 |
| METHOD FOR ASSESSING THE EFFECTIVENESS OF THE TREATMENT OF LIPIDEMIA | 2019 |
|
RU2694534C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF LIPIDEMIA | 2019 |
|
RU2714689C1 |
| DIAGNOSTIC TECHNIQUE FOR EARLY AND LATE STAGES OF LIPIDEMIA | 2019 |
|
RU2694538C1 |
| AGENT FOR METABOLIC SYNDROME CORRECTION | 2011 |
|
RU2458935C1 |
